153 related articles for article (PubMed ID: 23342389)
1. Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model.
Fernandes JC; Sereno J; Garrido P; Parada B; Cunha MF; Reis F; Pintado ME; Santos-Silva A
Mar Drugs; 2012 Dec; 10(12):2661-75. PubMed ID: 23342389
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
[TBL] [Abstract][Full Text] [Related]
3. Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model.
Sereno J; Parada B; Reis F; Cunha FX; Teixeira-Lemos E; Garrido P; Pinto R; Rocha-Pereira P; Neto P; Ruivo J; Rodrigues-Santos P; Nunes S; Mota A; Figueiredo A; Teixeira F
Mediators Inflamm; 2010; 2010():380937. PubMed ID: 21403827
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
Prabhu B; Balakrishnan D; Sundaresan S
Hum Exp Toxicol; 2016 Jun; 35(6):685-92. PubMed ID: 26251508
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties.
Parada B; Reis F; Pinto Â; Sereno J; Xavier-Cunha M; Neto P; Rocha-Pereira P; Mota A; Figueiredo A; Teixeira F
Int J Mol Sci; 2012; 13(7):8482-8499. PubMed ID: 22942715
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
7. Acetylsalicylic acid inhibition of n-butyl-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.
Klän R; Knispel HH; Meier T
J Cancer Res Clin Oncol; 1993; 119(8):482-5. PubMed ID: 8509438
[TBL] [Abstract][Full Text] [Related]
8. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
Kunze E; Schulz H; Adamek M; Gabius HJ
J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
[TBL] [Abstract][Full Text] [Related]
9. Effect of lupeol on antioxidants and xenobiotic enzymes in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
Prabhu B; Sivakumar A; Balakrishnan D; Sundaresan S
J Exp Ther Oncol; 2017 Sep; 11(2):139-416. PubMed ID: 28976137
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory, anti-proliferative and antioxidant profiles of selective cyclooxygenase-2 inhibition as chemoprevention for rat bladder carcinogenesis.
Parada B; Sereno J; Reis F; Teixeira-Lemos E; Garrido P; Pinto AF; Cunha MF; Pinto R; Mota A; Figueiredo A; Teixeira F
Cancer Biol Ther; 2009 Sep; 8(17):1615-22. PubMed ID: 19571668
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment.
Okajima E; Ozono S; Endo T; Majima T; Tsutsumi M; Fukuda T; Akai H; Denda A; Hirao Y; Okajima E; Nishino H; Nir Z; Konishi Y
Jpn J Cancer Res; 1997 Jun; 88(6):543-52. PubMed ID: 9263531
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of the aqueous extract of Magnolia officinalis on the responses of human urinary bladder cancer 5637 cells in vitro and mouse urinary bladder tumors induced by N-Butyl-N-(4-hydroxybutyl) nitrosamine in vivo.
Lee SJ; Cho YH; Park K; Kim EJ; Kang BS; Jung KH; Kim CH; Kim WJ; Moon SK
Phytother Res; 2009 Jan; 23(1):20-7. PubMed ID: 19048611
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer.
El-Ashmawy NE; Khedr EG; El-Bahrawy HA; Al-Tantawy SM
Tumour Biol; 2017 Feb; 39(2):1010428317692254. PubMed ID: 28218036
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Sugie S; Vinh PQ; Rahman KM; Ushida J; Kohno H; Suzuki R; Hara A; Quang le B; Tanaka T; Mori H
Int J Cancer; 2005 Nov; 117(4):524-30. PubMed ID: 15929075
[TBL] [Abstract][Full Text] [Related]
15. Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves.
Sato D; Matsushima M
Int J Urol; 2003 Mar; 10(3):160-6. PubMed ID: 12622713
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
Tyagi A; Raina K; Singh RP; Gu M; Agarwal C; Harrison G; Glode LM; Agarwal R
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3248-55. PubMed ID: 18089718
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention with green propolis green propolis extracted in L-lysine versus carcinogenesis promotion with L-lysine in N-Butyl-N-[4-hydroxybutyl] nitrosamine (BBN) induced rat bladder cancer.
Dornelas CA; Fechine-Jamacaru FV; Albuquerque IL; Magalhães HI; Souza AJ; Alves LA; Almeida PR; Lemos TL; Castro JD; Moraes ME; Moraes MO
Acta Cir Bras; 2012 Feb; 27(2):185-92. PubMed ID: 22378376
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
[TBL] [Abstract][Full Text] [Related]
19. Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Miyazawa K; Miyamoto S; Suzuki R; Yasui Y; Ikeda R; Kohno H; Yano M; Tanaka T; Hata K; Suzuki K
Oncol Rep; 2007 Feb; 17(2):297-304. PubMed ID: 17203164
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory action of alpha-difluoromethylornithine on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis.
Uchida K; Seidenfeld J; Rademaker A; Oyasu R
Cancer Res; 1989 Oct; 49(19):5249-53. PubMed ID: 2504487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
